Farrukh T Awan Selected Research

Farrukh T Awan Research Topics

Disease

32	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 01/2009
18	Neoplasms (Cancer) 10/2023 - 06/2007
8	Lymphoma (Lymphomas) 01/2023 - 01/2010
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 01/2012
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 10/2008
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 10/2018
5	Atrial Fibrillation 10/2023 - 09/2017
5	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 06/2016
3	Hypertension (High Blood Pressure) 01/2023 - 01/2022
3	Infections 10/2022 - 03/2017
3	Tumor Lysis Syndrome 10/2020 - 06/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 01/2015
3	Thrombocytopenia (Thrombopenia) 03/2017 - 12/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 05/2008
2	Heart Failure 01/2023 - 01/2022
2	Cardiotoxicity 01/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2008
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2019
2	Hemorrhage 01/2021 - 09/2017
2	Systemic Mastocytosis 01/2020 - 06/2016
2	Headache (Headaches) 01/2019 - 01/2018
2	Disease Progression 01/2018 - 01/2016
2	Neutropenia 03/2017 - 01/2015
2	Nausea 01/2015 - 06/2007
2	Multiple Myeloma 01/2012 - 01/2010
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2023
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2023
1	Sudden Death 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	COVID-19 10/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Ischemic Stroke 01/2021
1	Abnormal Karyotype 12/2020
1	Lymphocytosis 01/2020
1	Thrombosis (Thrombus) 11/2019
1	Opportunistic Infections (Opportunistic Infection) 10/2019
1	Cough 01/2019
1	Diarrhea 01/2019
1	Stroke (Strokes) 09/2017
1	Sepsis (Septicemia) 03/2017

Drug/Important Bio-Agent (IBA)

19	ibrutinibIBA 10/2023 - 01/2016
11	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 01/2016
6	acalabrutinibIBA 10/2022 - 01/2016
5	Rituximab (Mabthera)FDA Link 01/2023 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2014
3	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2019
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2023 - 07/2021
3	Lenalidomide (CC 5013)FDA Link 12/2020 - 01/2010
3	obinutuzumabIBA 11/2020 - 04/2014
3	venetoclaxIBA 11/2020 - 10/2018
3	Monoclonal AntibodiesIBA 10/2018 - 02/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
2	fludarabineIBA 01/2020 - 01/2009
2	midostaurinIBA 01/2020 - 06/2016
2	TRU 016IBA 01/2015 - 02/2014
2	Chlorambucil (Leukeran)FDA Link 04/2014 - 01/2009
1	Carmustine (FIVB)FDA Link 11/2023
1	COVID-19 VaccinesIBA 04/2023
1	VaccinesIBA 04/2023
1	Immunoglobulin G (IgG)IBA 04/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	GadoliniumIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	ChemokinesIBA 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 12/2020
1	Immunoglobulin Variable RegionIBA 01/2020
1	tisagenlecleucelIBA 12/2019
1	axicabtagene ciloleucelIBA 12/2019
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2019
1	Syk KinaseIBA 01/2019
1	AnthracyclinesIBA 01/2018
1	coltuximab ravtansineIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017
1	ofatumumab FDA Link 03/2017
1	idelalisibIBA 03/2017

Therapy/Procedure

30	Therapeutics 11/2023 - 01/2010
8	Cell Transplantation 01/2023 - 01/2012
6	Drug Therapy (Chemotherapy) 10/2023 - 06/2007
4	Homologous Transplantation 04/2021 - 04/2008
3	Transplantation 01/2023 - 12/2016
3	Salvage Therapy 01/2023 - 01/2016
3	Hematopoietic Stem Cell Transplantation 10/2008 - 04/2008
2	Aftercare (After-Treatment) 01/2023 - 01/2009
2	Immunotherapy 12/2019 - 01/2018
1	Radiotherapy 03/2023
1	Autologous Transplantation 02/2022
1	MDC protocol 01/2022
1	Thrombolytic Therapy 01/2021